approved EB-1A
Graduate Student
Translational Orthopedics · China · 2023-10-26
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.
Framework Evaluation
3 of 3 criteria metScholarly Articles (Met)
The petitioner published 26 peer-reviewed scientific articles in international journals.
Judging (Met)
The petitioner completed 17 peer reviews, acting as a judge of the work of other experts.
Original Contributions (Met)
His research on nanomedicines for bone cancer and 407 citations across 42 countries constitute original contributions of major significance.
Why This Petition Was Approved
The petition was approved based on meeting multiple EB-1A criteria, including 26 peer-reviewed scientific articles and a significant citation record of 407 citations. His participation in 17 peer reviews demonstrated his role as a judge of others' work. Additionally, his research received funding from several federal organizations, underscoring its national importance.
Evidence
Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Judging Experience
Original Contributions
Government Alignment
Evidence Submitted
- 26 peer-reviewed scientific articles in international journals
- 407 citations by peers in at least 42 countries
- 17 peer reviews conducted for journals in the field
- Funding support from several federal organizations
- Advanced degrees in clinical medicine, materials science, and a PhD in orthopedics
Similar Cases
Research Fellow
Biotechnology · China
WeGreened EB-1A approved
Massachusetts 15 days 2025-03-18
The petition was approved based on 7 peer-reviewed journal articles in high-impact publications and over 500 citations demonstrating global influence. Additionally, the petitioner completed over 90 peer reviews for leading journals, satisfying the judging criterion. These metrics, combined with evidence of original scientific contributions to medical innovation and biosecurity, met the EB-1A requirements.
Postdoctoral Researcher
Research and Development · India
WeGreened EB-1A approved
New York 13 days 2023-04-13
The approval was based on the petitioner's record of 25 peer-reviewed scientific articles which garnered 2,010 citations from researchers in at least 68 countries. Additionally, his participation in the field was evidenced by completing at least 21 peer reviews and demonstrating original contributions of major significance to biomedical research.
Lecturer
Biotechnology · China
WeGreened EB-1A rfe approved
112 days 2025-04-21
The petition was approved based on 12 peer-reviewed journal articles and a high citation count of 2,446. Additionally, the petitioner completed 30 peer reviews and secured funding from the National Natural Science Foundation of China (NSFC), satisfying the EB-1A criteria for scholarly articles, judging, and original contributions.
Others
Artificial Intelligence · China
WeGreened EB-1A approved
22 days 2026-01-09
The petition was approved based on a strong publication record of 18 peer-reviewed papers and over 800 citations spanning 21 countries. The petitioner also demonstrated significant professional standing through 50 completed peer reviews for selective journals and conferences. These metrics satisfied the EB-1A criteria for scholarly articles, original contributions, and judging roles.
Frequently Asked Questions
A approved EB-1A (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-10-26.
Browse all casesAt a Glance
Outcome approved
Processing 3 days
Criteria Met 3 / 3
Evidence Types 7
EB-1A Case Data
Scraped Case Data
Total Cases 881
Success Rate 52.9%
Sustained 466
Dismissed 299
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist